Companies
SM
STOXX 600Health Care· United Kingdom
SN
ChallengerSmith & Nephew
$1,263.00
+1.69%
Open $1,249.50·Prev $1,242.00
as of 14 Apr
CHALLENGER
Power Core
Smith & Nephew's moat, to the extent one exists, is a diversified medtech portfolio spanning orthopedics, sports medicine, and wound care that creates cross-selling leverage without single-segment dominance.
Published17 Apr 2026
UniverseSTOXX 600
SectorHealth Care
↑
Direction of Movement
upward
SN
Smith & Nephew
$1,263.00
+1.69%
Open $1,249.50·Prev $1,242.00
as of 14 Apr
↑Undervalued by 22%
DCF Fair Value: $1,611.91
News
No recent news available.
Market data unavailable